Waites G M
Clinic for Infertility and Gynaecological Endocrinology, University Hospital of Geneva, Switzerland.
Asian J Androl. 1999 Jun;1(1-2):7-12.
To present a personal account of the involvement of the World Health Organization (WHO) in the collaborative development in Asia of those areas of andrology concerned with male contraception and reproductive health.
The andrology training through workshops and institution support undertaken by the WHO Human Reproduction Programme (HRP) and how they contributed to the strengthening of andrology research in Asia are summarised.
The author' s experience and the Asian scientific contributions to the global research in the following areas are reviewed: the safety of vasectomy and the development of new methods of vas occlusion; gossypol and its failure to become a safe, reversible male antifertility drug; Tripterygium and whether its pure extracts will pass through the appropriate toxicology and phased clinical studies to become acceptable contraceptive drugs; hormonal methods of contraception for men.
The WHO policy of research capacity building through training and institution strengthening, together with the collaboration of Asian andrologists, has created strong National institutions now able to direct their own programmes of research in clinical and scientific andrology.
介绍世界卫生组织（WHO）参与亚洲男性学中与男性避孕和生殖健康相关领域合作发展的个人经历。
总结了WHO人类生殖计划（HRP）通过举办研讨会和提供机构支持开展的男性学培训，以及这些培训如何促进亚洲男性学研究的加强。
回顾了作者的经历以及亚洲在以下领域对全球研究的科学贡献：输精管切除术的安全性和新型输精管阻塞方法的开发；棉酚及其未能成为安全、可逆的男性抗生育药物；雷公藤及其纯提取物是否能通过适当的毒理学和分阶段临床研究成为可接受的避孕药；男性激素避孕方法。
WHO通过培训和加强机构建设来进行研究能力建设的政策，以及亚洲男性学家的合作，造就了强大的国家机构，这些机构现在有能力指导自己在临床和科学男性学方面的研究计划。
